We are committed to developing more affordable therapies so more patients have access to the medicine they need. Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in various therapeutic areas, including respiratory disease, allergy and opioid overdose.
The mission of Adamis is to provide high quality, lower-cost alternatives to existing therapies in various therapeutic areas to reach a broader range of patients. SYMJEPI (epinephrine) Injection is a lower-cost therapeutic epinephrine alternative in the anaphylaxis market.
The mission of Adamis is to provide high quality, lower-cost alternatives to existing therapies in various therapeutic areas to reach a broader range of patients. SYMJEPI (epinephrine) Injection is a lower-cost therapeutic epinephrine alternative in the anaphylaxis market.
Services
Dr. Carlo has extensive biotechnology research and development experience. At Hybritech Inc., the first biotechnology company in San Diego, he served as Vice President of Research and Development and Therapeutic Manufacturing. There, he managed a successful program to carry out research and development in the areas of monoclonal antibody and cancer therapy.
SYMJEPI (epinephrine) Injection is indicated for the emergency treatment of allergic reactions (Type 1- including anaphylaxis) to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
Adamis is currently developing products in various therapeutic areas including respiratory disease, allergy and opioid overdose. Adamis will pursue 505 (b) (2) regulatory approval filings whenever possible in order to minimize costs and shorten the time to market. The focus is to create high quality, lower-cost therapeutic alternatives to existing treatments.
Adamis Pharmaceuticals is a specialty biopharmaceutical company with products concentrated in allergy and respiratory illnesses. Adamis offers a fast-paced, highly collaborative work environment, as well as competitive benefits and compensation packages. Adamis seeks team members that are dedicated to our mission of reaching a broader range of patients by providing high quality, low-cost alternatives to existing allergy and respiratory therapies.
Adamis is looking to explore strategic commercial or development opportunities that advance our mission of providing high quality, lower-cost therapeutic options in the allergy and respiratory space. We believe that developing and strengthening the science and accessibility in these areas is essential to providing better treatment for patients.
Reviews
Be the first to review Adamis Viral Therapeutics.
Write a Review
